Advertisements

Stocking Stuffers

 

Ceapro Inc. (CZO:CA) Stock Quote

Detailed Quote for Ceapro Inc. (CZO:CA)
$ 0.39   -0.02 (-4.88%) Volume: 106.31k 3:27 PM EST Jan 17, 2020
Today 5d 1m 3m 1y more
Last Price
0.39
Change $
0.02
Change %
4.88%
Tick
  
Bid
0.39
Bid Size
10,000
Ask
0.405
Ask Size
5,000
Open
0.41
High
0.41
Low
0.39
Prev Close
0.41
Last Trade
01/17/20
Volume
106.31k
52 Wk Hi
0.50
52 Wk Low
0.27000001
Market Cap
30.16m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
77,335,841
EPS (TTM)
-0.019999999
PE Ratio
N/A
Exchange
TSXV
News and Media for Ceapro Inc. (CZO:CA)
Sector News | Topic News
News for Ceapro Inc. (CZO:CA)
Mon, Jan 06, 2020
9:00 AM Ceapro Announces Grant of Stock Options and Restricted Share Units - GlobeNewswire
Tue, Dec 17, 2019
8:00 AM Ceapro Inc. Announces Publication of Results for a New PGX Processed Chemical Complex in the Journal of Supercritical Fluids - GlobeNewswire
Wed, Nov 13, 2019
9:00 AM Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights - GlobeNewswire
Tue, Oct 29, 2019
8:05 AM Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides - GlobeNewswire
Wed, Oct 16, 2019
7:00 AM Ceapro Begins Trading on the OTCQX Best Market - GlobeNewswire
7:00 AM OTC Markets Group Welcomes Ceapro Inc. to OTCQX - PR Newswire
Wed, Sep 25, 2019
8:30 AM Ceapro to Present PGX Technology at the 3rd International Symposium on Pharmaceutical Engineering Research - GlobeNewswire
Tue, Sep 10, 2019
8:00 AM Ceapro Inc. to Present at the Fall Investor Summit in New York - GlobeNewswire
Wed, Aug 28, 2019
9:00 AM Ceapro Inc. Reports 2019 Second Quarter and Six-Month Financial Results and Operational Highlights - GlobeNewswire
Tue, Aug 27, 2019
8:45 AM Ceapro Announces Research Funding Award from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada for Joint Projects with McMaster University - GlobeNewswire
Thu, Aug 15, 2019
9:00 AM Ceapro Inc. Announces Signing of a Contribution Agreement with National Research Council of Canada - GlobeNewswire
Mon, Jun 10, 2019
4:05 PM Ceapro Announces Results of 2019 Shareholders' Meeting - GlobeNewswire
Wed, Jun 05, 2019
8:00 AM Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting - GlobeNewswire
Mon, Jun 03, 2019
9:00 AM Ceapro Inc. Commences Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent - GlobeNewswire
Thu, May 23, 2019
9:00 AM Ceapro Inc. Reports 2019 First Quarter Financial Results and Highlights - GlobeNewswire
Wed, May 15, 2019
9:00 AM Ceapro Inc. Announces Receipt of Site License from Health Canada - GlobeNewswire
Wed, Apr 24, 2019
8:00 AM Ceapro Inc. to Present at the ThinkEquity Conference in New York City - GlobeNewswire
Mon, Apr 15, 2019
8:05 AM Ceapro Inc. Announces Positive Key Findings from Three Oral Presentations Given at European Meeting on Supercritical Fluids - GlobeNewswire
Thu, Apr 11, 2019
9:00 AM Ceapro Inc. Reports Fourth Quarter and Full Year 2018 Results and Highlights - GlobeNewswire
Wed, Mar 27, 2019
8:05 AM Ceapro Announces Acceptance of Abstract for Presentation at the 2019 American College of Sports Medicine Annual Meeting - GlobeNewswire
More News for CZO:CA >>

Tags for Ceapro Inc.

Research stocks or mutual funds related to Ceapro Inc. by keywords or tags. Find companies that have a similar focus to CZO:CA. The keywords below have been associated to CZO:CA by either user submission or electronic means.

Pharmaceutical and Medicine Manufacturing (325410) Drugs Pharmaceutical and Medicine Industry (3741) Healthcare Common Stock